{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T21:53:32Z","timestamp":1676584412326},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.mehy.2010.04.007","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T05:16:46Z","timestamp":1273295806000},"page":"397-400","source":"Crossref","is-referenced-by-count":3,"title":["Niacin in the prevention of atherosclerosis: Significance of vasodilatation"],"prefix":"10.1016","volume":"75","author":[{"given":"P.","family":"Tuohimaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"J\u00e4rvilehto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2010.04.007_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.mehy.2010.04.007_bib2","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.mehy.2010.04.007_bib3","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.ATV.20.11.2459","article-title":"Macrophage cholesterol metabolism, apolipoprotein E, and scavenger receptor AI\/II mRNA in atherosclerosis-susceptible and -resistant mice","volume":"20","author":"Friedman","year":"2000","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"10.1016\/j.mehy.2010.04.007_bib4","author":"J\u00e4rvilehto","year":"2009","journal-title":"Vasa vasorum hypoxia: initiation of atherosclerosis medical hypotheses"},{"key":"10.1016\/j.mehy.2010.04.007_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1160\/TH06-12-0742","article-title":"Vasa vasorum and atherosclerosis \u2013 quid novi?","volume":"97","author":"Langheinrich","year":"2007","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.mehy.2010.04.007_bib6","first-page":"S260","article-title":"Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors","volume":"13 Suppl 10","author":"Davidson","year":"2007","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.mehy.2010.04.007_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/VHRM.S1653","article-title":"Clinical efficacy and safety of statins in managing cardiovascular risk","volume":"4","author":"Kapur","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.mehy.2010.04.007_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1527-3466.2008.00047.x","article-title":"Simvastatin: two decades in a circle","volume":"26","author":"Kolovou","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.mehy.2010.04.007_bib9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in coronary drug project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2010.04.007_bib10","doi-asserted-by":"crossref","first-page":"58B","DOI":"10.1016\/j.amjcard.2008.02.039","article-title":"Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk","volume":"101","author":"Brown","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2010.04.007_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.pharmtox.48.113006.094746","article-title":"Nicotinic acid: pharmacological effects and mechanisms of action","volume":"48","author":"Gille","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.mehy.2010.04.007_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/HCO.0b013e3283021c82","article-title":"Nicotinic acid: recent developments","volume":"23","author":"Kamanna","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.mehy.2010.04.007_bib13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1185\/030079904125004402","article-title":"Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid \u2013 a position paper developed by the European consensus panel on HDL-C","volume":"20","author":"Chapman","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.mehy.2010.04.007_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.hjr.0000277983.23934.c9","volume":"14 Suppl 2","author":"Graham","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.mehy.2010.04.007_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11883-007-0033-4","article-title":"Atherosclerosis and cardiovascular risk reduction with PPAR agonists","volume":"9","author":"Kuusisto","year":"2007","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.mehy.2010.04.007_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5551\/jat.E578","article-title":"Risk factors of atherosclerotic diseases. Executive summary of Japan atherosclerosis society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese","volume":"14","author":"Teramoto","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.mehy.2010.04.007_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.309.6946.23","article-title":"Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland","volume":"309","author":"Vartiainen","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2010.04.007_bib18","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2010.04.007_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/00365518909105414","article-title":"Nicotine does not affect plasma lipoprotein concentrations in healthy men","volume":"49","author":"Quensel","year":"1989","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.mehy.2010.04.007_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/157016107782023406","article-title":"Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms","volume":"5","author":"Rahman","year":"2007","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.mehy.2010.04.007_bib21","first-page":"13","article-title":"Syndrome X: 6 years later","volume":"736","author":"Reaven","year":"1994","journal-title":"J Intern Med Suppl"},{"key":"10.1016\/j.mehy.2010.04.007_bib22","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.CIR.99.16.2192","article-title":"Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy","volume":"99","author":"Rozanski","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2010.04.007_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1139\/y03-009","article-title":"Role of endothelin in human hypertension","volume":"81","author":"Touyz","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.mehy.2010.04.007_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.108.119420","article-title":"Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis","author":"Drager","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2010.04.007_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000092598","article-title":"Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C\/C genotype and established coronary artery disease","volume":"106","author":"Emre","year":"2006","journal-title":"Cardiology"},{"key":"10.1016\/j.mehy.2010.04.007_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2007.01.038","article-title":"Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease","volume":"196","author":"Cruz","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2010.04.007_bib27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MCO.0b013e328312c33f","article-title":"Vitamin D in the prevention and treatment of coronary heart disease","volume":"11","author":"Zittermann","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.mehy.2010.04.007_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2006.09.011","article-title":"Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors","volume":"191","author":"Roberts","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2010.04.007_bib29","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/PL00012505","article-title":"Statins: the new aspirin?","volume":"59","author":"Veillard","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.mehy.2010.04.007_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11883-007-0007-6","article-title":"Alcohol and atherosclerosis: recent insights","volume":"9","author":"Tolstrup","year":"2007","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.mehy.2010.04.007_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/157488407780598135","article-title":"Ethanol metabolism and effects: nitric oxide and its interaction","volume":"2","author":"Deng","year":"2007","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.mehy.2010.04.007_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/157016107781024091","article-title":"Beneficial effects of statins on endothelial dysfunction and vascular stiffness","volume":"5","author":"Dilaveris","year":"2007","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.mehy.2010.04.007_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2337\/dc07-2199","article-title":"Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients","volume":"31","author":"Koh","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2010.04.007_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1167\/iovs.06-0856","article-title":"Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways","volume":"48","author":"Nagaoka","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2010.04.007_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MCA.0b013e3282f2066e","article-title":"Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat","volume":"19","author":"van der Harst","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.mehy.2010.04.007_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1476-7120-5-51","article-title":"The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease","volume":"5","author":"Yildiz","year":"2007","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.mehy.2010.04.007_bib37","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1172\/JCI27160","article-title":"Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid","volume":"115","author":"Pike","year":"2005","journal-title":"J Clin Invest"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:20:11Z","timestamp":1559082011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987710001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0306987710001817"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2010.04.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}